The story of Viagra, and its parent company copyright, presents a intriguing case study for investors. Initially a blockbuster drug, yielding billions in revenue , its exclusivity period created a flood of https://apollobookmarks.com/story21350394/sildenafil-and-pharma-a-risky-opportunity